PureTech Health plc
CIK: 0001782999
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPTX
Seaport Therapeutics, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About PureTech Health plc
PureTech Health plc (SEC CIK 0001782999) files insider reports with the SEC as 10% Owner of Seaport Therapeutics, Inc. (SPTX).
Signal8 holds 1 ownership filing by PureTech Health plc, a Form 4, filed on May 6, 2026. Those filings report 3 transactions, the latest on May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PureTech Health plc's filings is in BOSTON, MA.
Recent filings by PureTech Health plc
- May 4, 2026: Conversions of SPTX shares (3 lines, Form 4, code C).
Other insiders filing for Seaport Therapeutics, Inc. (SPTX)
- HOMBACH ROBERT J., Director
- GAP Coinvestments CDA, L.P., Director
- General Atlantic (SP), L.P., Director
- Zohar Daphne, Chief Executive Officer
- HEALY JAMES, Director
- White Lauren, Chief Financial Officer